Related Experiment Video
Updated: Jul 5, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation
Xinsong Xu1, Antonio Sarikas, Dora C Dias-Santagata
1Department of Oncological Sciences, The Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Abstract:
Recent genetic studies have documented a pivotal growth-regulatory role played by the Cullin 7 (CUL7) E3 ubiquitin ligase complex containing the Fbw8-substrate-targeting subunit, Skp1, and the ROC1 RING finger protein. In this report, we identified insulin receptor substrate 1 (IRS-1), a critical mediator of the insulin/insulin-like growth factor 1 signaling, as a proteolytic target of the CUL7 E3 ligase in a manner that depends on mammalian target of rapamycin and the p70 S6 kinase activities. Interestingly, while embryonic fibroblasts of Cul7-/- mice were found to accumulate IRS-1 and exhibit increased activation of IRS-1's downstream Akt and MEK/ERK pathways, these null cells grew poorly and displayed phenotypes reminiscent of those associated with oncogene-induced senescence. Taken together, our findings demonstrate a key role for the CUL7 E3 in targeting IRS-1 for degradation, a process that may contribute to the regulation of cellular senescence.
Insights
The Cullin 7 (CUL7) E3 ligase targets insulin receptor substrate 1 (IRS-1) for degradation. This regulation by CUL7 is crucial for controlling cellular senescence and cell growth.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- The Cullin 7 (CUL7) E3 ubiquitin ligase complex, comprising Fbw8, Skp1, and ROC1, is recognized for its role in growth regulation.
- Insulin receptor substrate 1 (IRS-1) is a key mediator in insulin and insulin-like growth factor 1 (IGF-1) signaling pathways.
Purpose of the Study:
- To identify substrates of the CUL7 E3 ligase complex.
- To investigate the role of CUL7 in the regulation of IRS-1 and cellular senescence.
Main Methods:
- Identification of IRS-1 as a proteolytic target of the CUL7 E3 ligase.
- Analysis of CUL7-dependent IRS-1 degradation, involving mammalian target of rapamycin (mTOR) and p70 S6 kinase (S6K) activities.
- Phenotypic analysis of embryonic fibroblasts from Cul7-/- mice.
Main Results:
- CUL7 E3 ligase targets IRS-1 for degradation in a process dependent on mTOR and S6K.
- Cul7-/- mouse embryonic fibroblasts accumulate IRS-1, showing increased activation of downstream Akt and MEK/ERK pathways.
- Cells lacking CUL7 exhibit poor growth and phenotypes associated with oncogene-induced senescence.
Conclusions:
- The CUL7 E3 ligase plays a critical role in targeting IRS-1 for proteasomal degradation.
- Regulation of IRS-1 by CUL7 is a significant factor in controlling cellular senescence.
- This CUL7-mediated degradation pathway may be a key mechanism in regulating cell growth and preventing premature aging.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Insulin: The Receptor and Signaling Pathways
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

